Release date: 2016-04-06
Recently, Forbes published an analysis article that looks at the technology trends in the medical field over the next five years. Although Singular Cake believes that this prediction is optimistic, it does not make sense. However, these five technologies do have the potential to subvert the health care industry.
Artificial intelligence intelligent auxiliary diagnosis is popular
Artificial intelligence (AI) can depict and mimic human brain functions through machines or software. The application of AI in the medical and health industry is mainly through the analysis of medical knowledge stored in the program, in order to help doctors improve the treatment of patients, thus providing a better treatment. When there is an urgent need, AI can provide doctors and researchers with clinically relevant, real-time, high-quality information from data stored in electronic health records (EHRs).
AI's healthcare application market is growing at a CAGR of 42% and is expected to reach global popularity in 2021. Outstanding treatment results, lower treatment costs, unnecessary hospitalizations, simpler workflows, and patient-centered treatments are top reasons why AI is widely accepted and rapidly growing in the healthcare industry.
By 2020, chronic diseases such as cancer and diabetes can be detected in a matter of minutes, primarily through a cognitive system that recognizes typical physiological features and projects real-time 3D images onto the screen. By 2025, AI systems will account for 90% of all US hospitals and insurance companies, accounting for 60% of the world. The AI ​​system provides 70% of patients with more convenient and cheaper quality care.
With the help of digital image processing, pattern recognition and machine learning artificial intelligence platforms, AI can obtain more accurate and reliable medical image analysis. For example, a startup, Butterfly Network, has developed a handheld 3D ultrasound tool that creates real-time 3D medical images and sends them to the cloud server, which can help identify pathological features and auto-diagnose. Clinical support for AI like this will have a significant impact on the overall development of medical imaging diagnostics.
Through advanced facial recognition and motion sensing software to observe patients and demonstrate compliance with artificial intelligence medications, innovative, automated patient guidance and solutions like this have begun in one of the main processes of medical care – direct observation Used in treatment (DOT). New market competitors with similar treatment options will quickly capture this market segment.
IBM Watson Health recently acquired Truven Health Analytics for $2.6 billion, creating a new and important dimension of health data analysis, and IBM's already strong health care market position has been further strengthened.
Great potential for immunotherapy
The advantage of immunotherapy is reflected in the transformation of the immune system's treatment of tumors and cancer. It has developed new areas that have improved patient survival and survival rates. For example, malignant melanoma has a large therapeutic need, but there are currently only a limited number of treatments. More than 160,000 melanomas are diagnosed every year worldwide, including 40,000 deaths.
Immunotherapy can be widely applied to different patient populations. Once this therapy is found to be effective in treating tumors, its development potential is enormous. Despite the clinical dominance of checkpoint inhibitors, there are still other promising therapies, such as the construction of new molecules, chimeric antigen receptors (CARs), combination therapy of new and old drugs, and dosing regimens. Modifications, and the use of vaccines. The market value of checkpoint inhibitors in 2015 was US$3 billion, which is expected to reach 21.1 billion by 2020, calculated at a compound annual growth rate of 139%.
Body fluid biopsy: potential non-invasive detection of tumors
The humoral biopsy technique is a minimally invasive cancer detection technology that enables minimally invasive, real-time, and rapid cancer diagnosis by analyzing tumor-associated analytical markers or cells in the blood, and is highly likely to disrupt the detection and diagnosis of cancer. Nowadays, in order to study ever-changing tumors, repeated biopsies are needed, which is also a huge challenge for patients. Body fluid biopsy provides a very attractive investment opportunity for diagnostic companies. Blood biomarkers, such as ctDNA and CTCs, have begun to track and monitor tumors in a non-invasive manner. In the next two years or so, body fluid biopsy will become an auxiliary form of tissue biopsy. The effectiveness of this technology has been proven, and even worsened disease conditions can be detected before CT examinations. The most critical advantage of this technology compared to tissue biopsy is that it does not require “finding the root cause of the diseaseâ€.
CRISPR/Cas9 (RT) is widely used in drug development
CRISPR/Cas9 is a gene editing technology that enables targeted, accurate, and reliable modification of DNA. It has the ability to transform R&D pathways and develop products in key areas of the global life sciences economy. In 2014, the technology began to receive attention from outsiders, and companies used technology to develop therapeutic drugs. Sangamo Biosciences is the company that uses one of the most widely used technologies, zinc finger nucleases, to develop clinical treatments for human diseases. Other startups, such as CRISPR Therapeutics and Editas Medicine, have focused on CRISPR technology and have received millions of VC investments.
When gene therapy is used in the treatment of human diseases, there are areas where technologies such as agriculture and special-purpose chemicals have surpassed market research. Gene editing helps in the following situations:
Modify key traits in crops and animals
Increase food crop yield and nutrition quotient
Cultivate crops that are resistant to natural disasters, pests or extreme weather
Cultivate strong, disease-resistant animal breeds by improving nutrient types
Some people have analyzed the funding project involving the CRISPR/Cas9 from the National Institutes of Health from 2013 to 2015 and found that this very promising gene editing technology has developed rapidly. From 2013 to 2014, capital investment increased by 7 times, and from 2014 to 2015, the capital has more than doubled. The CRISPR/Cas9 technology has a major impact in the field of disease treatment and will not end up at the scientific level. This technology overcomes many of the difficulties of genome editing tools such as RNAi, TALENs and ZFN, and may yield hundreds of millions of market value in the next few years.
3D printing: changing the rules of the game in the organ or tissue repair industry
3D printing technology has great potential in the healthcare industry because of its unique customization capabilities. Customization can greatly reduce the operation time and medical expenses. Currently, the most widely used applications are 3D printed stents or prostheses (medical implant materials) such as dental implants and hearing aids. What really makes 3D printing an industry changer is human tissue printing: printing the liver, heart, ears, hands and eyes or the construction of minimal functional units to the production of large tissues and organs. These can be used as surgical grafts to repair or replace damaged tissues and organs.
It is estimated that more than one million people worldwide need kidney transplants worldwide. However, because of the insufficient number of donor organs, only 5,000 more patients are truly transplantable. The shortage of legally donated organs has led to a sharp increase in the global illegal organ trade. By 2025, the healthcare industry's 3D printing companies will be able to value about $6 billion. Among the 3D printing companies in the healthcare industry are Stratasys Ltd., Arcam AB, Organovo Holdings Inc., Johnson & Johnson, Services Inc. and Stryker.
These five technologies have great potential to transform the entire healthcare industry.
Source: Singularity Network
Digital Radiography made affordable, Created to meet the needs of community to hospitals and private radiology practices, it enables the price-sensitive customers to join the drive to go digital.The versatile floor mounted radiography system enables you to go from film to CR to DR. Flooe-mounted easy for installation and operation.
The United-imaging is floor mounted system comprises a radiographic table with integral floor guide rail and a wallstabd. Requiring little room preparation, it is easy to install.
United-imaging according to the international advanced processing mode and standardlize design. the parts are made with precision CNC machine and moulding. Which adopt high degree of standardized, reasonable and compact structure. With reliable, durable and elegant appearance and advanced processing technology.
X-Ray Digital Machine,X-Ray Digital Machine In Medical,X-Rays Digital Medical Machine,Medical X-Ray Digital Imaging Machine
Shanghai Rocatti Biotechnology Co.,Ltd , https://www.shljdmedical.com